How do you pay?

How to pay the least

Ask for the cash price

Fotivda

We didn’t find one.

  1. Ask your pharmacy for Fotivda’s cash price, and one or two other pharmacies too.
  2. Fotivda’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameFotivda
Authorized generictivozanib
Regular generictivozanib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Fotivda?
The original
–
–

Brand nameThe maker’s card

AVEO ACE CoPay Assistance Program

Savings card from AVEO Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a year

The card takes up to $25,000 a year off your co-pay.

Sign up on fotivda.com 

Or call 1-833-368-4832.

In the maker’s words

“Eligible patients could pay as little as $0 for their FOTIVDA prescription, up to $25,000 per calendar year.”

From the maker’s offer on fotivda.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Fotivda itself, from the same company, sold without the brand name, and usually for less. For now Fotivda is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

FOTIVDA is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.

Source: the FDA label for Fotivda (AVEO Pharmaceuticals, Inc.), September 15, 2026. Full label on DailyMed 

Good to know